Search - tctmd.com

Displaying 341 - 360 of 4220

Sort: Relevancy | Date

News Conference News TCT 2024

New DanGer Shock Data: Hemodynamics, Renal Dysfunction, and Bleeding

Caitlin E. Cox

October 28, 2024

News Conference News TCT 2024

Protecting Coronary Access After TAVI: Valve Choice Clues From CAVEAT

Michael O'Riordan

October 27, 2024

Podcast TCTMD Talking Points

The ECLS-SHOCK Trial

October 23, 2024

News Daily News

SOUL: Oral Semaglutide Cuts CV Events in Diabetic Patients

L.A. McKeown

October 23, 2024

News Conference News EACTS 2024

At EACTS 2024, Surgeons and Cardiologists Move Past EXCEL Firestorm

Yael L. Maxwell

October 22, 2024

News Daily News

Practical Strategies to Foster Diversity in Cardiology Clinical Trials

Caitlin E. Cox

October 22, 2024

News Conference News EACTS 2024

‘Teleprehabilitation’ Before Cardiac Surgery Improves the Outcomes That Follow

Yael L. Maxwell

October 17, 2024

News Conference News EACTS 2024

AI-Based CT Can Accurately Screen Patients for TMVR

Yael L. Maxwell

October 15, 2024

News Daily News

Lp(a) Levels, Still Mostly Genetic, Sometimes Vary Over a Lifetime

Michael O'Riordan

October 14, 2024

News Conference News EACTS 2024

MACE in CV Trials: Has the Outcome Outlived Its Role?

Yael L. Maxwell

October 11, 2024

News Daily News

Small Fraction of STEMI Patients With Shock Meet DanGer Criteria

Caitlin E. Cox

October 11, 2024

News Daily News

COVID-19 Increases MACE Risk Nearly 3 Years Later: UK Biobank

Todd Neale

October 10, 2024

News Conference News EACTS 2024

Will Semaglutide Change Cardiac Surgery? It Already Has

Yael L. Maxwell

October 10, 2024

News Daily News

APPRAISE ATP Highlights the Trade-offs of Antitachycardia Pacing

Todd Neale

October 09, 2024

Podcast TCTMD Talking Points

The STOPDAPT-3 Trial

October 09, 2024

News Daily News

Different Guidelines for Acute PE Offer a Mixed Bag of Advice

Caitlin E. Cox

October 08, 2024

News Conference News HFSA 2024

Biomarker and Echo Data Bolster Vutrisiran’s Promise in ATTR-CM

L.A. McKeown

October 04, 2024

News Conference News HFSA 2024

EXPANDed: Atrial Secondary MR Patients Get Clinical Benefit From TEER

Caitlin E. Cox

October 03, 2024

News Conference News HFSA 2024

‘Metabolic Accelerator’ Cuts Weight, Not Muscle in HFpEF: HuMAIN-HF

Michael O'Riordan

October 03, 2024

News Conference News HFSA 2024

‘Global Efficacy’ of Aficamten for Obstructive Disease Shown in SEQUOIA-HCM

L.A. McKeown

October 02, 2024

Advertisement

New DanGer Shock Data: Hemodynamics, Renal Dysfunction, and Bleeding

Protecting Coronary Access After TAVI: Valve Choice Clues From CAVEAT

The ECLS-SHOCK Trial

SOUL: Oral Semaglutide Cuts CV Events in Diabetic Patients

At EACTS 2024, Surgeons and Cardiologists Move Past EXCEL Firestorm

Practical Strategies to Foster Diversity in Cardiology Clinical Trials

‘Teleprehabilitation’ Before Cardiac Surgery Improves the Outcomes That Follow

AI-Based CT Can Accurately Screen Patients for TMVR

Lp(a) Levels, Still Mostly Genetic, Sometimes Vary Over a Lifetime

MACE in CV Trials: Has the Outcome Outlived Its Role?

Small Fraction of STEMI Patients With Shock Meet DanGer Criteria

COVID-19 Increases MACE Risk Nearly 3 Years Later: UK Biobank

Will Semaglutide Change Cardiac Surgery? It Already Has

APPRAISE ATP Highlights the Trade-offs of Antitachycardia Pacing

The STOPDAPT-3 Trial

Different Guidelines for Acute PE Offer a Mixed Bag of Advice

Biomarker and Echo Data Bolster Vutrisiran’s Promise in ATTR-CM

EXPANDed: Atrial Secondary MR Patients Get Clinical Benefit From TEER

‘Metabolic Accelerator’ Cuts Weight, Not Muscle in HFpEF: HuMAIN-HF

‘Global Efficacy’ of Aficamten for Obstructive Disease Shown in SEQUOIA-HCM

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content